Tennis star Iga Swiatek has received a suspension after testing positive for a banned substance.
The world No. 2 tested positive for heart medication trimetazidine (TMZ) in an out-of-competition sample in August 2024.
Here’s when she is set to return to the court.
MORE: Who is the world No.1 in women’s tennis? Updated WTA rankings
How long is Iga Swiatek’s doping suspension?
Swiatek has received a one-month suspension.
The International Tennis Integrity Agency (ITIA) accepted the player’s explanation that the positive test was a result of contamination of regulated non-prescription medication melatonin.
The medication was manufactured and sold in Poland and was taken by Swiatek for jet lag and sleep issues.
As a result, her level of fault was considered to be at the lowest end of the range for ‘No Significant Fault or Negligence’.
Swiatek was provisionally suspended after her US Open quarter-final loss, which saw her miss the Korea Open, China Open and Wuhan Open.
Her suspension was not made public, with her absence attributed to personal matters and a coaching change.
Swiatek was provisionally suspended from September 12 before making a successful appeal.
Her provisional suspension was lifted on October 4, and she returned to the court in November at…
